Table 2.

Differential cytology analysis and flow cytometry in patients with lung cancer (n = 14), patients with ILD (n = 10) and patients with asthma (n = 10). Values are given in median [IQR]

Cell type	Lung cancer	ILD	Asthma
Macrophages (%) [IQR]	87.5 [61.8; 94.8]	82 [55.3; 92.3]	85 [77.3; 91.8]
Lymphocytes (%) [IQR]	8.5 [5; 18]	17.5 [6.5; 43]	15 [8.3; 18]
Neutrophils (%) [IQR]	0 [0; 0.75]	1 [0; 1.75]	0 [0; 1.75]
Eosinophils (%) [IQR]	0 [0; 0]	0 [0; 0]	0 [0; 0.75]
T lymphocytes subtypes
T cells CD3 + (% of all 45 + cells)	4.22 [1.26; 22.2]	7.82 [4.73; 26.95]	14.5 [9.17; 25.38]
T cells CD4 + (% of all 45 + cells)	1.93 [0.355; 8.11]	4.21 [1.92; 14.35]	7.41 [5.91; 18.55]
T cells CD8 + (% of all 45 + cells)	1.49 [0.22; 6.48]	2.6 [1.45; 6.47]	3.35 [1.66; 6]
CD279 + (% of CD4 + cells)	66.4 [59; 69.25]	83.1 [72.1; 87.48]	61.3 [57.38; 70.53]
CD279 + (% of CD8 + cells)	77.1 [35.83; 82.25]	73.75 [60.33; 86.28]	57.25 [45.98; 65]